Nusinersen Sodium Injection

DRUG2 trials

Sponsors

Biogen

Conditions

Muscular Atrophy, Spinal

Unknown Phase

Observational, Postmarketing Surveillance Study of Spinraza Injection (Nusinersen Sodium)

Active, not recruitingNCT04317794

BiogenMuscular Atrophy, Spinal

Start: 2019-07-02End: 2027-02-05Updated: 2026-07-27

Non-Interventional, Postmarketing Surveillance Study of Nusinersen Sodium Injection

CompletedNCT04419233

BiogenMuscular Atrophy, Spinal

Start: 2020-11-18End: 2023-11-21Updated: 2023-12-07

Related Papers

A Post-Marketing Surveillance Study of Nusinersen for Spinal Muscular Atrophy in Routine Medical Practice in China: Interim Results

Advances in Therapy2024-05-093 citations